研究者
J-GLOBAL ID:202401016501207763   更新日: 2024年11月22日

工藤 麗

クドウ レイ | Kudo Rei
研究分野 (1件): 腫瘍生物学
競争的資金等の研究課題 (2件):
  • 2024 - 2026 がんに対する新規核酸医薬療法の前臨床試験
  • 2014 - 2016 乳癌におけるリン酸化酵素DYRK2の発現制御機構の解明-治療法開発を目指して-
論文 (18件):
  • Rei Kudo, Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R Dry, Hong Shao, Sharanya Nag, Edaise M da Silva, Selma Yeni Yildirim, Qing Li, et al. Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion. Cancer cell. 2024. 42. 11. 1983-1983
  • Rei Kudo, Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R Dry, Hong Shao, Sharanya Nag, Edaise M da Silva, Selma Yeni Yildirim, Qing Li, et al. Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion. Cancer cell. 2024
  • Qing Li, Baishan Jiang, Jiaye Guo, Hong Shao, Isabella S Del Priore, Qing Chang, Rei Kudo, Zhiqiang Li, Pedram Razavi, Bo Liu, et al. INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors. Cancer discovery. 2022. 12. 2. 356-371
  • Eijiro Nagasaki, Rei Kudo, Miho Tamura, Kazumi Hayashi, Tadashi Uwagawa, Yoshikazu Kijima, Hiroko Nogi, Hiroshi Takeyama, Masafumi Suzuki, Masako Nishikawa, et al. Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report. Breast cancer (Tokyo, Japan). 2021. 28. 5. 1051-1061
  • Atsushi Fushimi, Rei Kudo, Hiroshi Takeyama. Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response?. Clinical breast cancer. 2020. 20. 1. e82-e88
もっと見る
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る